BreezeBio Venture Capital
4 known investors
BreezeBio develops a programmable delivery platform called NanoGalaxy for targeted delivery of genetic medicines to specific cells and tissues. The platform addresses the challenge of enabling genetic payloads to reach their target sites in the body to control biological processes.
Investors Β· 4
Frequently asked questions
- What does BreezeBio Venture Capital do?
- BreezeBio develops a programmable delivery platform called NanoGalaxy for targeted delivery of genetic medicines to specific cells and tissues. The platform addresses the challenge of enabling genetic payloads to reach their target sites in the body to control biological processes.
- Who are BreezeBio Venture Capital's investors?
- BreezeBio Venture Capital's investors include Blue Bear Ventures, Bow Capital, IMM Investment Japan, DCVC (Data Collective).